Bonesupport Holding AB (publ) (STO:BONEX)

Market Cap	15.25B -20.1%
Revenue (ttm)	1.22B +21.8%
Net Income	185.11M +51.3%
EPS	2.77 +50.7%
Shares Out	65.86M
PE Ratio	83.60
Forward PE	42.60
Dividend	n/a
Ex-Dividend Date	n/a

Volume	238,479
Open	233.40
Previous Close	235.40
Day's Range	227.60 - 236.00
52-Week Range	165.00 - 346.40
Beta	0.48
Analysts	Strong Buy
Price Target	373.83 (+61.41%)
Earnings Date	Jul 16, 2026

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone gra...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 160
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BONEX

Financial Performance

In 2025, Bonesupport Holding AB's revenue was 1.17 billion, an increase of 30.70% compared to the previous year's 898.73 million. Earnings were 142.15 million, an increase of 6.28%.